CIPLA.NS · NSI · Healthcare
Cipla Limited
Also onConsensus Drift
Implied value per share
INR 834.41
Market price
INR 1394.50
Implied upside
-40.2%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (INR). Outflows negative.
| Line | FY27 | FY28 | FY29 | FY30 | FY31 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | INR 297.2bn | INR 318.7bn | INR 341.7bn | INR 366.4bn | INR 392.9bn | +7.2% |
| EBIT | INR 58.8bn | INR 63.0bn | INR 67.6bn | INR 72.5bn | INR 77.7bn | +7.2% |
| NOPAT | INR 44.0bn | INR 47.1bn | INR 50.5bn | INR 54.2bn | INR 58.1bn | +7.2% |
| Add depreciation & amortisation | INR 12.1bn | INR 12.9bn | INR 13.9bn | INR 14.9bn | INR 16.0bn | +7.2% |
| Less capital expenditure | INR -20.3bn | INR -21.8bn | INR -23.4bn | INR -25.1bn | INR -26.9bn | +7.2% |
| Less increase in working capital | INR -7.9bn | INR -8.4bn | INR -9.0bn | INR -9.7bn | INR -10.4bn | +7.2% |
| Free cashflow to firm | INR 27.8bn | INR 29.8bn | INR 32.0bn | INR 34.3bn | INR 36.8bn | +7.2% |
| Discount factor | 0.9541 | 0.8687 | 0.7908 | 0.7200 | 0.6555 | - |
| Present value | INR 26.5bn | INR 25.9bn | INR 25.3bn | INR 24.7bn | INR 24.1bn | -2.4% |
| Present Value Of The Forecast | INR 126.6bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 6.80% | INR assumption - no free live source available for this market (assumption) |
| Equity risk premium | 8.00% | Market assumption |
| Beta | 0.382 | Reported 0.078, pulled toward 1.0 (Blume) |
| Cost of equity | 9.86% | Risk-free + beta x equity risk premium |
| Cost of debt | 9.17% | Interest expense / average total debt |
| Market capitalisation | INR 1126.6bn | 99.5% of capital |
| Total debt | INR 6.1bn | 0.5% of capital, book value as a proxy |
| Tax rate | 25.2% | Effective, capped at statutory |
| WACC | 9.84% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
78% of EV
- Forecast FCFF, final year
- INR 36.8bn
- Capex at depreciation, working capital in reinvestment
- INR 60.7bn
- Less reinvestment at g/ROIC (18.3% of NOPAT)
- INR -11.1bn
- Capitalised
- INR 49.6bn
- ROIC (reported)
- 13.6%
- Terminal value, undiscounted
- INR 692.1bn
- Terminal value, discounted
- INR 453.7bn
- Enterprise value
- INR 580.3bn
- Less net debt
- INR -94.1bn
- Equity value
- INR 674.4bn
Exit at 17.4x EBITDA
89% of EV
- Terminal value, undiscounted
- INR 1630.8bn
- Terminal value, discounted
- INR 1068.9bn
- Enterprise value
- INR 1195.5bn
- Less net debt
- INR -94.1bn
- Equity value
- INR 1289.7bn
Spread between methods: 63%.
Sensitivity
Value per share (INR) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 7.84% | 1042.16 | 1077.16 | 1118.35 | 1167.64 | 1227.83 |
| 8.84% | 907.92 | 929.32 | 953.79 | 982.13 | 1015.43 |
| 9.84% | 806.28 | 819.56 | 834.41 | 851.17 | 870.28 |
| 10.84% | 726.75 | 734.96 | 743.95 | 753.87 | 764.90 |
| 11.84% | 662.90 | 667.83 | 673.11 | 678.80 | 684.97 |
Outlined: this model. Green text: above today's price of 1394.50. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 7.2% | 24.0% | +16.8pp |
| EBIT margin | 19.8% | 33.9% | +14.1pp |
| Discount rate | 9.8% | 6.7% | -3.1pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.